openPR Logo
Press release

Pneumococcal Vaccines Market is driven by development of new vaccines

03-05-2018 02:52 PM CET | Health & Medicine

Press release from: TMR - Research Report

/ PR Agency: TMR - Research Report
Pneumococcal Vaccines Market is driven by development of new

The World Health Organization (WHO) projects that Streptococcus Pneumoniae kills nearly half a million children under the 5 years of age across the globe every year, especially in the developing countries. However, there has been a reduction in the disease in the regions that provide Pneumococcal Conjugate Vaccines (PCV). Introduction of vaccines around the world has significantly reduced disease burden, notably in the developing countries. Key market players are also entering into a partnership to ensure that supply of the pneumococcal vaccines remains stable. Manufacturers are also focusing on developing countries as various organizations are investing in these developing nations to help in the research and development and delivery of vaccines in order to reduce mortality rate due to the diseases.

Read Report Overview: https://www.transparencymarketresearch.com/pneumococcal-vaccines-market.html

Various government and private sector organizations are taking initiatives to provide vaccination, especially for the low income group and at the same time create awareness among the people about various diseases. Child mortality rate due to pneumonia has also reduced significantly due to pneumococcal vaccines. The latest developed vaccines that fight against infections of 13 and 23 pneumococcal serotypes are Pneumovax23 and Prevnar 13. However, the most comprehensive vaccine to fight against 72 forms of S. Pneumoniae is still under development. Meanwhile, in order to maintain the quality of vaccines, manufacturers, distributors and others in the supply chain are following cold chain procedure, recommended by WHO. The increasing incidence of drug resistance against bacteria of pneumonia disease is driving the need for cost-effective treatment and also giving rise to the R&D of new pneumococcal vaccines.

Sanofi, Merck & Co. Inc., GlaxoSmithKline PLC, and Pfizer, Inc. are some of the key market players in the global pneumococcal vaccines market.

Request Sample of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=36536

Global Pneumococcal Vaccines Market to Witness Strong Growth during the Forecast Period 2017-2026

As per the latest study by Transparency Market Research (TMR), the global pneumococcal vaccines market is expected to experience strong growth. The market is estimated to register 8.3% CAGR during the forecast period 2017-2026. By the end of 2026, the global pneumococcal vaccines market is also estimated to reach US$ 20,515.5 million revenue.

The global pneumococcal vaccines market is segmented into distribution channel, product type, and region. Based on the product type, the market is divided into 10- valent PCV, 7- valent PCV, 13- valent PCV, and 23- valent PPSV. Among the given product types, 13- valent PCV is expected to be the largest product type in the global pneumococcal vaccines market during the forecast period.

By distribution channel, the market segment includes clinics, hospitals, and other distribution channels. Hospitals are expected to be largest distribution channel for pneumococcal vaccines during 2017-2026.

Download Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=36536

North America to Dominate the Global Pneumococcal Vaccines Market from 2017 to 2026

North America is expected to remain dominant in the global pneumococcal vaccines market. Introduction of the Pneumococcal Conjugate Vaccines (PCV) in the U.S. and Canada and the routine immunization schedule in these countries has proven to be highly effective in reducing pneumonia and pneumococcal disease. Moreover, factors such as increasing investment by the government and private sector organizations, and the development of new vaccines have also contributed to the growth in the region. According to the US Centers for Disease Control and Prevention (CDC), the introduction of 7-valent vaccine in Canada and the U.S. significantly reduced Invasive Pneumococcal Disease (IPD) among children. Meanwhile, efforts are being taken by government and private sector organizations to introduce pneumococcal vaccines in developing countries under various programs.

About us:
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pneumococcal Vaccines Market is driven by development of new vaccines here

News-ID: 964920 • Views: 127

More Releases from TMR - Research Report

Global Tissue Extraction System Market: Trends and Opportunities 2017 - 2025
Global Tissue Extraction System Market: Overview The global tissue extraction system market is foretold to display an impressive growth rate in the coming years. This could be owing to the need for tissue extraction or biopsy for cancer analysis after the patient has been suspected of carrying the disease. The procedure is extremely vital for diagnosing the disease. Thus, increasing prevalence of carcinogenic agents, compromised immunity levels, and rising incidence of
Neurology Sterile Injectable Market: Growth Factors, Applications, Regional Anal …
Neurology sterile injectables are generally administered to individuals suffering from pain linked to the nerves. Neuropathic pain injections are used to provide relief to these individuals. Neurology sterile injectable block the pain signal from reaching the brain. Neurological sterile injection can be administered at sympathetic nervous system, trigger points, dorsal roots, and peripheral nerves. The most commonly use neurological injectable used for nerve block are steroid injection, opioids, and local
External Fixator Devices Market: Global Survey and Trend Research
External fixator devices are used to stabilize and support long bone open fractures to help the patient carry body’s weight as well as movement. Schanz screws, connecting rods, and clamps are used in case of unipolar external fixators. Circulatory fixators include circular rings, wires, connecting rods, and struts. The external fixator devices provide rigid fixation along with fixed distraction of the fracture fragments. The major advantage of external fixator devices
Anorectal Preparations Market Trends, and Forecast 2017 - 2025
Anorectal preparations are products that contain a combination of an anti-inflammatory agent, or a pain reliever, and a local anesthetic as a suppository, or an ointment. External or internal hemorrhoids are treated by the topical application of anorectal preparations. Hemorrhoids are masses or lumps of tissue in the anus that contain enlarged blood vessels. The formation of hemorrhoids is due to an increase in abdominal pressure. Frequent constipation, which is

All 5 Releases


More Releases for Pneumococcal

Pneumococcal Vaccine Report on Global Pneumococcal Vaccine Market Development, p …
Latest Survey on Pneumococcal Vaccine Market: The Global Pneumococcal Vaccine market report value has been estimated considering the application and regional segments, market share, and size, while the forecast for each product type and application segment has been provided for the global markets. The Pneumococcal Vaccine report offers detailed profiles of the key players to bring out a clear view of the competitive landscape of the Pneumococcal Vaccine Outlook. It also
Pneumococcal Vaccines Market | North America Dominated the Global Market
Transparency Market Research (TMR) has published a new report titled, “Pneumococcal Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global pneumococcal vaccines market was valued at US$ 7,247.6 Mn in 2017 and is anticipated expand at a CAGR of 3.3% from 2018 to 2026. Increase in patient pool, growth of the pharmaceutical industry, government initiatives to increase vaccination programs, rise
Global Pneumococcal Vaccine Industry Market Analysis & Forecast 2018-2023
Global Pneumococcal Vaccine Industry Market results in aggravation noticeable all around sacs (known as alveoli) of the lungs, which brings about filling the alveoli with liquid (discharge cells), accordingly causing breathing issues. Pneumococcal Vaccine illness is regular in youthful youngsters, however more established grown-ups are at most serious danger of genuine pneumococcal diseases and even demise. Get sample copy of report: https://www.marketdensity.com/contact?ref=Sample&reportid=4396 Table of Contents 1 Industry Overview 1.1 Pneumococcal Vaccine Industry 1.1.1
Pneumococcal Vaccines Market to Undertake Strapping Growth During 2018 – 2028
Future Market Insights (FMI) delivers the key insights on the global pneumococcal vaccines market in its upcoming report titled "Pneumococcal Vaccines Market: Global Industry Analysis 2013–2017 and Opportunity Assessment 2018 – 2028". In terms of revenue, the global pneumococcal vaccines market is projected to register a CAGR of 9.1% over the forecast period. North America is expected to contribute a high revenue share in the global pneumococcal vaccines market over the
Global Pneumococcal Vaccine Market Review 2018-2023 Pfizer, MSD, Sanofipasteur
A market study "Global Pneumococcal Vaccine Market" examines the performance of the Pneumococcal Vaccine market 2018. It encloses an in-depth Research of the Pneumococcal Vaccine market state and the competitive landscape globally. This report analyzes the potential of Pneumococcal Vaccine market in the present and the future prospects from various angles in detail. The Global Pneumococcal Vaccine Market 2018 report includes Pneumococcal Vaccine market Revenue, market Share, Pneumococcal Vaccine industry volume,
Pneumococcal Vaccines Market Estimated to Flourish at by 2026
Global Pneumococcal Vaccines Market- Overview The prevention of disease through vaccination is one of the most cost-effective and safe ways. Pneumococcus is one of the leading causes of blood infection, pneumonia, sinusitis, meningitis, and otitis media. It is also one of the leading infectious diseases. In-Depth research report on Pneumococcal Vaccines Market : https://www.xploremr.com/report/135/pneumococcal-vaccines-market However, it can be prevented with the help of vaccination. With an increase in pneumococcal disease due to